The case stems from a bacterial contamination at a Michigan plant from 2018 to 2022.

The allegations stem from Abbott’s failure to manufacture certain powder infant formula and nutritional therapy products at its Sturgis, Michigan and Casa Grande, Arizona facilities in compliance with federal and state statutory, regulatory, and contractual requirements between January 1, 2018 and December 31, 2022.

Abbott Laboratories will pay over $384M after selling baby formula from taxpayer-funded programs in unsafe conditions, with Oregon receiving close to $1M from the settlement.

Both Medtronic and Abbott have raised their dividends for nearly half a century, but retirement investors with limited capital can only choose one. The case for each is stronger than most comparisons admit, and the tiebreaker comes down to a single question about your timeline.

Analyst endorsement surfaces: Social media conversations have centered on TD Cowen's recent reaffirm

Analyst endorsement surfaces: Social media conversations have centered on TD Cowen's recent reaffirm

Abbott Laboratories stock is trading near USD 103 on September 11, 2026 as Citi reiterates a Buy rat

Abbott Laboratories (ABT) live stock price today, chart, open, previous close, market cap, company profile and related united states market data on TechGraph.